← Back to Search

Remote Monitoring of Home Exercise in Peripheral Arterial Disease (ROMEPAD Trial)

N/A
Waitlist Available
Led By Subhash Banerjee, MD, MBA
Research Sponsored by Dallas VA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare two groups of people with peripheral arterial disease - those who do home exercise with a digital monitoring system and provider supervision, and those who just use the monitoring system.

Eligible Conditions
  • Peripheral Arterial Disease
  • Peripheral Artery Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in 6 minute walk test distance between groups
Secondary study objectives
Change in VascuQOL-6 (VQ6) quality of life survey
Change in Walking Impairment Questionnaire score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Provider SupervisedExperimental Treatment1 Intervention
Digital monitoring system with provider supervision
Group II: Self SupervisedActive Control1 Intervention
Digital monitoring system without provider supervision

Find a Location

Who is running the clinical trial?

Dallas VA Medical CenterLead Sponsor
34 Previous Clinical Trials
4,780 Total Patients Enrolled
1 Trials studying Peripheral Arterial Disease
12 Patients Enrolled for Peripheral Arterial Disease
Subhash Banerjee, MD, MBAPrincipal InvestigatorDallas VA Hospital
~14 spots leftby Dec 2025